✦ LIBER ✦

1029 POSTER A phase II study of sorafenib (BAY 43–9006) in patients with recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC) and nasopharyngeal cancer (NPC)

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

47 POSTER A phase II study of Sorafenib

✍ C. Elser; L. Siu; E. Winquist; M. Agulnik; G. Pond; S. Chin; P. Francis; R. Chei 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 60 KB

995 ORAL A phase II trial of BAY 43–9006

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 137 KB

A phase II study of sunitinib in patient

✍ George Fountzilas; Anna Fragkoulidi; Anna Kalogera-Fountzila; Martha Nikolaidou; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 639 KB

Phase II study of paclitaxel, ifosfamide

✍ Dong M. Shin; Fadlo R. Khuri; Bonnie S. Glisson; Lawrence Ginsberg; Vali M. Papa 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

Erlotinib and bevacizumab in patients wi

✍ Ezra EW Cohen; Darren W Davis; Theodore G Karrison; Tanguy Y Seiwert; Stuart J W 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 442 KB

A phase II study of temsirolimus and erl

✍ Bauman, Julie E.; Arias-Pulido, Hugo; Lee, Sang-Joon; Fekrazad, M. Houman; Ozawa 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 496 KB